Share on LinkedInShare on LinkedIn

ARTICLE · 19 SEPTEMBER 2018

One-Year Anniversary Of The CSP Regulations

Gowling WLG
Gowling WLG
Contributor
Gowling WLG

Gowling WLG

The firm The firm’s lawyers speak English, French, Russian and Ukrainian. The firm’s client base...

View firm profile
Explore more from Gowling WLG

On September 21, 2017, the Certificate of Supplementary Protection Regulations ("CSP Regulations") came into force ...

CanadaIntellectual Property

On September 21, 2017, the Certificate of Supplementary Protection Regulations ("CSP Regulations") came into force, providing for the first time the ability to obtain an extended period of patent protection for human and veterinary drugs in Canada. With the first anniversary of the program quickly approaching, an overview of its implementation may prove useful and highlight key information for the coming years. For an in depth look at the CSP Regulations, we have previously provided a detailed overview available here.1

What is a Certificate of Supplementary Protection?

Briefly, a Certificate of Supplementary Protection ("CSP") is a form of sui generis protection for newly approved pharmaceutical products protected by an eligible patent, for a period of up to two years following expiry of the patent. The CSP Regulations were implemented in accordance with Canada's obligations under the Canada-European Union Comprehensive Economic and Trade Agreement ("CETA"),

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from